Alfimeprase to succeed Genentech's alteplase?
Vastag
Brian
B
D001777:Blood Coagulation; D004345:Drug Industry / Q000191:economics* / Q000639:trends; D005343:Fibrinolytic Agents / Q000191:economics / Q000627:therapeutic use; D006801:Humans; D008666:Metalloendopeptidases / Q000191:economics* / Q000627:therapeutic use*; D013927:Thrombosis / Q000188:drug therapy* / Q000191:economics*; D010959:Tissue Plasminogen Activator / Q000191:economics* / Q000627:therapeutic use*; D014481:United States
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator; D008666:Metalloendopeptidases; C436755:alfimeprase